| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/15/1997 | CA2069063C Processes for the diastereoselective synthesis of nucleosides |
| 07/10/1997 | WO1997024443A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | WO1997024359A1 Novel cephalosporin derivatives and processes for the preparation thereof |
| 07/10/1997 | WO1997024358A1 Process for preparation of cefdinir |
| 07/10/1997 | WO1997024343A1 Phenyl thiazole derivatives with anti herpes virus properties |
| 07/10/1997 | WO1997024138A2 Medical use of proteases |
| 07/10/1997 | WO1997024137A1 HYBRID WITH INTERFERON-α AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 07/10/1997 | WO1997024128A1 Otic microbial combinations |
| 07/10/1997 | WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2241280A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | CA2239522A1 Hybrid with interferon-.alpha. and an immunoglobulin fc linked through a non-immunogenic peptide |
| 07/09/1997 | EP0783038A1 Recombinant viral pseudoparticles and their applications as vaccines or as antitumour agents |
| 07/09/1997 | EP0782631A1 Treatment of plasmodium |
| 07/09/1997 | EP0782627A1 Genetically altered t-cells |
| 07/09/1997 | EP0782620A1 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 07/09/1997 | EP0782615A1 Dna encoding human papillomavirus type 6a |
| 07/09/1997 | EP0782456A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 07/09/1997 | EP0782455A1 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 07/09/1997 | EP0782454A1 Use of muramyl peptide compounds |
| 07/09/1997 | EP0782443A1 Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt |
| 07/09/1997 | CN1154123A Antiviral dendrimers |
| 07/09/1997 | CN1154111A New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 07/09/1997 | CN1154110A Compounds useful as antiproliferative agents and GARFT inhibitors |
| 07/09/1997 | CN1153651A Medicine for parotitis and its prepn |
| 07/09/1997 | CN1035357C Preparation for medicinal liquid composition containing triazoles compound and a solvent system |
| 07/08/1997 | US5646294 Orally active azole derivatives |
| 07/08/1997 | US5646262 Binds encapsidation sequence of messenger rna intermediate; genetic engineering |
| 07/08/1997 | US5646261 3'-derivatized oligonucleotide analogs with non-nucleotidic groupings, their preparation and use |
| 07/08/1997 | US5646259 DNA encoding haemophilus adhesion proteins |
| 07/08/1997 | US5646180 Treatment of the CNS effects of HIV |
| 07/08/1997 | US5646163 Quinolone 5-(N-heterosubstituted amino) antimicrobials |
| 07/08/1997 | US5646155 Drugs to prevent recurrent herpes virus infections |
| 07/08/1997 | US5646150 Methods of using lavendamycin analogs |
| 07/08/1997 | US5646148 Piperazinylbenzofuran derivatives |
| 07/08/1997 | US5646141 Compounds useful as antiproliferative agents and GARFT inhibitors |
| 07/08/1997 | US5646139 Antimicrobial carbapenem quinolones |
| 07/08/1997 | US5646121 Pseudopeptides with antiviral activity |
| 07/08/1997 | US5646119 D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents |
| 07/08/1997 | US5646111 Cyclic peptide antifungal Agents |
| 07/08/1997 | US5646110 Cyclic peptides |
| 07/08/1997 | US5646033 African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5646014 Peptide, antibacterial agent, peptide gene, recombinant DNA and method for preparing the peptide |
| 07/08/1997 | US5645983 Elisa, antibody-antigen complex |
| 07/08/1997 | US5645836 Toxin conjugated to monoclonal antibody, then crosslinked, reverse transcriptase inhibitor |
| 07/08/1997 | US5645830 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 07/08/1997 | CA2081970C Hiv protease inhibitors useful for the treatment of aids |
| 07/03/1997 | WO1997023637A1 Galactopyranosides and their use |
| 07/03/1997 | WO1997023628A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
| 07/03/1997 | WO1997023622A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023620A1 Novel tcts response regulator of staphylococcus aureus |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023505A1 Two component signal transducing system protein from staphylococcus aureus |
| 07/03/1997 | WO1997023504A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
| 07/03/1997 | WO1997023501A1 Therapeutic compositions |
| 07/03/1997 | WO1997023495A1 Water soluble antibiotics |
| 07/03/1997 | WO1997023494A1 Carbohydrate conjugated bio-active compounds |
| 07/03/1997 | WO1997023465A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/03/1997 | WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | WO1997023243A1 Branched hydrazone linkers |
| 07/03/1997 | WO1997023238A1 Stabilisers for live vaccines |
| 07/03/1997 | WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | WO1997023221A1 Method for treating dermatitis |
| 07/03/1997 | WO1997023217A1 Injectable quinolone formulations |
| 07/03/1997 | CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | CA2241129A1 Therapeutic compositions |
| 07/03/1997 | CA2241105A1 Staphylococcus aureus coenzyme a disulfide reductase, and inhibitors thereof useful as antimicrobial agents |
| 07/03/1997 | CA2240941A1 Galactopyranosides and their use |
| 07/03/1997 | CA2240836A1 Method for treating dermatitis |
| 07/03/1997 | CA2240767A1 Water soluble antibiotics |
| 07/03/1997 | CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2213489A1 Carbohydrate conjugated bio-active compounds |
| 07/02/1997 | EP0781776A2 Water soluble rapamycin esters |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781546A1 A multi-layered film preparation |
| 07/02/1997 | EP0781353A1 System for electrolyzing fluids for in vivo administration to humans and other warm blooded mammals |
| 07/02/1997 | EP0781344A1 Novel implant and novel vector for the treatment of acquired diseases |
| 07/02/1997 | EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/02/1997 | EP0781332A2 Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens |
| 07/02/1997 | EP0781141A1 Aza cyclohexapeptide compounds |
| 07/02/1997 | EP0781138A2 Lipid analogs for treating viral infections |
| 07/02/1997 | EP0781095A1 Cells bearing cd4 decoy receptors and related molecules and methods |
| 07/02/1997 | EP0544713B1 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 07/01/1997 | US5644053 Beta-lactamase inhibitors or bactericide antibiotics |
| 07/01/1997 | US5644051 Intermediates for the preparation of carbacephems |
| 07/01/1997 | US5644035 Method for purifying secreted Mac-2-binding glycoprotein |
| 07/01/1997 | US5643964 Natural amino acid derivatives as metalloproteinase inhibitors |
| 07/01/1997 | US5643935 Method of combatting infectious diseases using dicationic bis-benzimidazoles |
| 07/01/1997 | US5643929 Treatment of picornaviral or rhinovirus and chemical intermediates |
| 07/01/1997 | US5643924 Retroviral protease inhibitors |
| 07/01/1997 | US5643893 Antiinflammatory agents or antiarthritic agents |
| 07/01/1997 | US5643879 Oligopeptide enzyme inhibitors as hypotensive agents |
| 07/01/1997 | US5643875 Proteins and endotoxins |
| 07/01/1997 | US5643869 Pipecolic acid-containing peptolides, their preparation and pharmaceutical compositions containing them |
| 07/01/1997 | US5643778 RNA editing enzyme and methods of use thereof |
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
| 07/01/1997 | US5643608 Low pH germicidal iodine compositions having enhanced stability |